Literature DB >> 3653233

Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers.

D A Goldstein1, Y K Tan, S J Soldin.   

Abstract

Salbutamol was administered to sixteen healthy male volunteers intravenously and by mouth in liquid, tablet, and capsule form using a Latin-Squares design. Pharmacokinetic parameters from intravenous data were similar to previously reported values obtained with oral administration, with a mean terminal half-life of 3.8 h and a mean clearance of 439 ml X min-1 X 1.73 m-2. Peak plasma concentrations of 10-20 ng X ml-1 were obtained 1-3 h following oral administration. The absolute bioavailability of each of the oral preparations was 44%. While statistically significant differences in lag time and time to peak concentration were noted among the various oral preparations, the drug is rapidly absorbed in all three dosage forms and the observed differences are unlikely to be of clinical significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653233     DOI: 10.1007/BF02456001

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  The clinical pharmacology of oral and inhaled salbutamol.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  Clin Pharmacol Ther       Date:  1972 Nov-Dec       Impact factor: 6.875

2.  Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

3.  Analysis of beta-sympathicomimetics in man with high performance liquid chromatography using mode sequencing and electrochemical detection.

Authors:  B Oosterhuis; M C Braat; C J van Boxtel
Journal:  Eur J Respir Dis Suppl       Date:  1984

4.  Plasma concentrations of salbutamol after an oral slow-release preparation.

Authors:  J G Maconochie; P Fowler
Journal:  Curr Med Res Opin       Date:  1983       Impact factor: 2.580

5.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

6.  Determination of salbutamol in human serum by reversed-phase high-performance liquid chromatography with amperometric detection.

Authors:  Y K Tan; S J Soldin
Journal:  J Chromatogr       Date:  1984-11-28

7.  Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels.

Authors:  A J Fairfax; W R McNabb; H J Davies; S G Spiro
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

8.  Comparative bioavailability and pharmacokinetics of three formulations of albuterol.

Authors:  M L Powell; M Weisberger; R Gural; M Chung; J E Patrick; E Radwanski; S S Symchowicz
Journal:  J Pharm Sci       Date:  1985-02       Impact factor: 3.534

  8 in total
  14 in total

1.  Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Authors:  Akash Khandelwal; Praveen M Bahadduri; Cheng Chang; James E Polli; Peter W Swaan; Sean Ekins
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

2.  Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.

Authors:  B J Lipworth; D G McDevitt; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

Review 3.  The pharmacokinetics of levosalbutamol: what are the clinical implications?

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

4.  Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; T A Moreland; A D Struthers; G A Clark; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Effect of salbutamol on digoxin pharmacokinetics.

Authors:  M Edner; T Jogestrand; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 6.  Enantioselective disposition of albuterol in humans.

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 7.  Drug therapy approaches in the treatment of acute severe asthma in hospitalised children.

Authors:  L K DeNicola; M O Gayle; K V Blake
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

8.  Pharmacokinetics of intravenous salbutamol in renal insufficiency and its biological effects.

Authors:  E Rey; L Luquel; M O Richard; B Mory; G Offenstadt; G Olive
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  Relative importance of intestinal and hepatic glucuronidation-impact on the prediction of drug clearance.

Authors:  Helen E Cubitt; J Brian Houston; Aleksandra Galetin
Journal:  Pharm Res       Date:  2009-01-31       Impact factor: 4.200

10.  Development and characterization of Eudragit based mucoadhesive buccal patches of salbutamol sulfate.

Authors:  Prasanth Viswanadhan Vasantha; Ayarivan Puratchikody; Sam Thomarayil Mathew; Ashok Kumar Balaraman
Journal:  Saudi Pharm J       Date:  2011-07-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.